Centrient Pharmaceuticals International B.V.
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 28 Jan 2026 | Rainer Becker Director | Exchange of view on access to medicines | — |
| 28 Jan 2026 | Rainer Becker Director | Exchange of view on access to medicines | SRC |
| 30 Jun 2022 | Maria Luisa Llano Cardenal Cabinet member | Pharmaceutical Strategy | SRC |
| 30 Jun 2022 | Maria Luisa Llano Cardenal Cabinet member | Pharmaceutical Strategy | — |
| 14 Jan 2022 | Maurits-Jan Prinz Cabinet member | Security of supply of pharmaceutical ingredients and intermediates | — |
| 14 Jan 2022 | Maurits-Jan Prinz Cabinet member | Security of supply of pharmaceutical ingredients and intermediates | SRC |
| 15 Sept 2020 | Eszter Batta Cabinet member | Strengthening the EU’s production capacity for live-saving pharmaceuticals. | — |
| 15 Sept 2020 | Eszter Batta Cabinet member | Strengthening the EU’s production capacity for live-saving pharmaceuticals. | SRC |
Mission & Goals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We are a pharmaceutical company with a mission to improve lives by being at the centre of sustainable and accessible healthcare.
EU Legislative Interests
EU Pharmaceutical Strategy, EU Healthcare Policy, EU Industrial Policy, EU Environmental Policy (Green Deal), EU Trade Policy, AMR Policy
Communication Activities
Not applicable this year
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
AMR Industry Alliance
Organisation Members
AMR Industry Alliance